Increases in Fibroblast Growth Factor 23 During Treatment With Ferric Carboxymaltose: Potential Adverse Effects on the Heart and Kidneys. Packer M. J Card Fail 2023;29:229-231.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Packer M. Increases in Fibroblast Growth Factor 23 During Treatment With Ferric Carboxymaltose: Potential Adverse Effects on the Heart and Kidneys. J Card Fail 2023;29:229-231.
PMID: 36410653